Yahoo Finance25d
Blue Lake Biotechnology to Present Safety and Immunogenicity Data for its RSV Intranasal Vaccine Candidate at the 13th International RSV Symposium
Blue Lake Biotechnology is developing BLB201 as an intranasal vaccine to prevent acute and severe disease associated with RSV infection. Phase 1 clinical trial results demonstrate BLB201's safety ...
Morningstar25d
Blue Lake Biotechnology to Present Safety and Immunogenicity Data for its RSV Intranasal Vaccine Candidate at the 13th International RSV Symposium
Blue Lake Biotechnology to Present Safety and Immunogenicity Data for its RSV Intranasal Vaccine Candidate at the 13th International RSV Symposium Blue Lake Biotechnology, Inc., a clinical-stage ...
Business Wire25d
Blue Lake Biotechnology to Present Safety and Immunogenicity Data for its RSV Intranasal Vaccine Candidate at the 13 th International RSV Symposium
ATHENS, Ga. & SAN JOSE, Calif.--(BUSINESS WIRE)--Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness ...
Le Lézard8d
Preclinical Intranasal COVID-19 Vaccine Candidate Data Demonstrate Durable Immune Response and Broad Protection
Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...
Yahoo Finance8d
Preclinical Intranasal COVID-19 Vaccine Candidate Data Demonstrate Durable Immune Response and Broad Protection
ATHENS, Ga. & SAN JOSE, Calif., March 27, 2025--(BUSINESS WIRE)--Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored ...
Le Lézard8d
Labtician Ophthalmics, Inc. Introduces LabtmTRIACTIV: The Next Evolution in Dry Eye Management
Labtician Ophthalmics, Inc. is proud to announce the launch of LabtmTRIACTIV, a transformative artificial tear designed to redefine dry eye relief. Powered by advanced cationic liposomal technology, ...
BioSpace25d
Blue Lake Biotechnology to Present Safety and Immunogenicity Data for its RSV Intranasal Vaccine Candidate at the 13th International RSV Symposium
ATHENS, Ga. & SAN JOSE, Calif.--(BUSINESS WIRE)--Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the ...
PipelineReview.com8d
Preclinical Intranasal COVID-19 Vaccine Candidate Data Demonstrate Durable Immune Response and Broad Protection
ATHENS, GA & SAN JOSE, CA, USA I March 27, 2025 I Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the ...
Eagle Pharmaceuticals Announces $69 Million Agreement to Monetize BENDEKA® Royalties
Under the terms of the agreement, Eagle will receive $69 million before transaction costs as an upfront payment in exchange for a prespecified amount of Eagle’s royalty interest for net sales of ...
The Globe and Mail15d
Parainfluenza Virus Infection Market to Expand Significantly by 2034, States DelveInsight Report | Ansun Biopharma, AlloVir, MedImmune
In November 2024, Blue Lake Biotechnology, Inc., a clinical-stage company specializing in intranasal vaccines using parainfluenza virus 5 (PIV5)-vectored technology to activate the full immune ...
Hosted on MSN29d
Scientists Create Woolly Mouse with Traits of Extinct Mammoth
The so-called "Colossal Woolly Mouse" was developed by Colossal Biosciences, a biotechnology company based ... spot crashed plane in icy Alaska lake Ukraine Hits Fifth North Korean Artillery ...